Tvardi Therapeutics, Inc. (TVRD) Earnings History
Net Loss6 years of earnings data (2020–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Tvardi Therapeutics, Inc. (TVRD) Earnings Overview
As of June 29, 2026, Tvardi Therapeutics, Inc. (TVRD) reported trailing twelve-month net income of -$14M, reflecting +93.0% year-over-year growth. The company earned $-1.44 per diluted share over the past four quarters.
Looking at the long-term picture, TVRD's historical earnings data spans multiple years. The company achieved its highest annual net income of $8M in fiscal 2020.
Tvardi Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), KYMR (-$315M net income, -794.4% margin), AUPH ($298M net income, 101.5% margin), TVRD has comparable earnings metrics. Compare TVRD vs IMVT →
TVRD Earnings vs Peers
Earnings metrics vs comparable public companies
TVRD Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$18M | +74.3% | -$27M | $-3.26 | - | - |
| 2024 | -$71M | +40.2% | -$56M | $-46.59 | -993.0% | -781.6% |
| 2023 | -$119M | -38.7% | -$121M | $-1.85 | -565.2% | -579.4% |
| 2022 | -$85M | +3.4% | -$88M | $-2.20 | -204.2% | -209.1% |
| 2021 | -$88M | -1151.6% | -$89M | $-62.77 | -384.1% | -386.8% |
| 2020 | $8M | - | $5M | $6.32 | 6.2% | 4.0% |
Download Data
Export TVRD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TVRD — Frequently Asked Questions
Quick answers to the most common questions about buying TVRD stock.
What is TVRD earnings per share (EPS)?
TVRD trailing twelve-month (TTM) diluted EPS is $-1.44, reflecting +93.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.
What is Tvardi Therapeutics, Inc.'s net income?
Tvardi Therapeutics, Inc. (TVRD) trailing twelve-month net income is $-14M as of 2025. Earnings grew +93.0% year-over-year.
Is TVRD profitable?
TVRD is not currently profitable on a TTM basis, reporting a net loss of $-14M. Net margin is N/A. Investors should monitor for a return to profitability.
What is TVRD's earnings growth rate?
TVRD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.
What are TVRD's profit margins?
Tvardi Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -222.8%.
Is TVRD growing earnings?
Yes, TVRD earnings are accelerating — EPS growth of +93.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-14M. Earnings momentum is strengthening.
What was TVRD's best earnings year?
Tvardi Therapeutics, Inc.'s highest annual net income on record is $8M, achieved in fiscal year 2020. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.
What were TVRD's earnings last quarter?
TVRD's most recent reported quarter was Q4 2025. Net income was $-7M with diluted EPS of $-0.78. For a full breakdown of all quarters, see the quarterly earnings table on this page.